Skip to main content
Sign In
 

PARTICIPATION IN RHEUMATOLOGY RESEARCH


The Rheumatology Division at the University of Colorado has numerous ongoing clinical research studies. Our human research studies are divided into two main areas: 

1) Treatment trials which involve the use of new therapies for disease

2) Studies on the development and prevention of diseases such as rheumatoid arthritis and lupus

Currently enrolling:

  •  Complement Receptor 2 as a Biomarker for Systemic Lupus Erythematosus
  •  Role of Complement Receptor 2 in systemic lupus Erthymatosus 

  

                                             

 

For more information on any of our studies, please try the following links:

 

 

      • Rheumatoid arthritis
      • Psoriatic arthritis
      • Lupus
      • Other rheumatologic disease

 

 

      • Sera Study
        • SERA is identifying established and new, potentially important blood and genetic markers.
        • SERA is looking for the presence of various autoantibodies* in the blood of healthy people. These autoantibodies may be present before physical symptoms of the disease are evident. 
        • SERA is also looking at possible environmental factors that could contribute to RA.
        • SERA’s findings may lead to earlier diagnosis, and possible prevention of RA in the future.